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Head-to-tail backbone cyclization of proteins is a widely
used approach for the improvement of protein stability.
One way to obtain cyclic proteins via recombinant expres-
sion makes use of engineered Intein tags, which are self-
cleaving protein domains. In this approach, pH-induced
self-cleavage of the N-terminal Intein tag generates an N-
terminal cysteine residue at the target protein, which then
attacks in an intramolecular reaction the C-terminal thioe-
ster formed by the second C-terminal Intein tag resulting
in the release of the cyclic target protein. In the current
work we aimed to produce a cyclic analog of the small
g-Ec-1 domain of the wheat metallothionein, which con-
tains six cysteine residues. During the purification process
we faced several challenges, among them premature cleav-
age of one or the other Intein tag resulting in decreasing
yields and contamination with linear species. To improve
efficiency of the system we applied a number of optimiza-
tions such as the introduction of a Tobacco etch virus cleav-
age site and an additional poly-histidine tag. Our efforts
resulted in the production of a cyclic protein in moderate
yields without any contamination with linear protein
species.
Keywords: cyclic proteins/cysteine/intein tags/
metallothionein/TEV protease
Introduction
In backbone cyclized or circular proteins, the N- and
C-termini are covalently joined by an amide bond. This
protein class is widely found in nature (Trabi and Craik,
2002). The largest family of naturally occurring circular pep-
tides are the well-known cyclotides, which are mainly
observed in plants (Gran, 1973; Gustafson et al., 1994;
Witherup et al., 1994; Saether et al., 1995). More recently, a
number of cyclic bacterial proteins distinct from cyclotides
were discovered (Langdon et al., 1998; Blond et al., 1999;
Gonzalez et al., 2000; Abriouel et al., 2001; Rebuffat et al.,
2004). Circular peptides can have numerous functions
showing for example uterotonic (Gran, 1973), anti-HIV
(Gustafson et al., 1994), antimicrobial (Tam et al., 1999b),
and insecticidal activity (Wang et al., 2009). The cyclized
backbone is often crucial for protein functionality with the
linear analogs showing decreased or even a loss of activity
(Blond et al., 1999) and increases the in vivo stability of circu-
lar peptides against proteolytic degradation (Iwai and
Plu¨ckthun, 1999) as well as the stability against certain chemi-
cals (Bogdanowich-Knipp et al., 1999) and heat denaturation
in vitro (Gonzalez et al., 2000; Zhao et al., 2010). An addition-
al benefit for many applications is the reduced flexibility of the
protein structure imposed by the fixation of the protein termini
within the cycle, as protein ends usually have a higher entropy
than the protein core. This can for example improve receptor
binding affinities of circular proteins in comparison to the cor-
responding linear proteins (Luckett et al., 1999; Korsinczky
et al., 2001). The versatile properties of circular peptides make
them attractive for the development of, e.g. drugs or pesticides
and hence everywhere where stability and target binding affin-
ity are major determinants of efficacy (Craik et al., 2002;
Armishaw et al., 2011). In addition, the generation of circular
protein analogs provides a tool for manipulation and under-
standing of protein structure and folding mechanism as well as
the investigation of splicing reactions (Camarero et al., 2001;
Heitz et al., 2008).
Different synthetic strategies for the production of cyclic
proteins can be found in the literature (White and Yudin,
2011) among them native chemical ligation and traceless
Staudinger ligation that both afford head-to-tail cyclization via
a native amide bond. Native chemical ligation uses an unpro-
tected synthetic linear peptide with a C-terminal a-thioester
and an N-terminal Cys residue that is required for the intramo-
lecular transthioesterification reaction to yield the cyclic inter-
mediate (Dawson et al., 1994). The native amide bond is
subsequently formed after a spontaneous S-N acyl rearrange-
ment. The traceless Staudinger ligation abolishes the need for
an N-terminal Cys residue and thus is applicable to any amino
acid sequence (Tam and Raines, 2009). For the reaction, a
bifunctional phosphinothiol is coupled to the C-terminus of a
synthetic peptide resulting in a thioester and a free phosphino
group that can undergo a Staudinger reaction with another
peptide carrying an N-terminal azide group. The formed imi-
nophosphorane intermediate further reacts with the thioester to
afford the native amide bond after hydrolysis. Initially applied
for the ligation of two peptide fragments, the traceless
Staudinger ligation was recently also applied for the synthesis
of cyclic peptides (Ha et al., 2012).
Also recombinant techniques can be used for the prepar-
ation of cyclic peptides and proteins in moderate yields, which
is especially attractive for larger ring sizes that are not access-
ible by synthetic methods. The main methods are expressed
protein ligation (EPL) (Xu and Evans, 2001; Muir, 2003),
protein trans splicing (PTS) (Tavassoli and Benkovic, 2007),
trans-peptidation (Parthasarathy et al., 2007) and genetic
reprogramming (Ohta et al., 2008). The first two approaches are
most commonly used and are based on the use of engineered
inteins. Inteins are self-cleaving protein domains involved in
protein splicing. The mechanism of intein-mediated splicing
includes four conserved steps: a spontaneous and reversible
N!S acyl shift to a thioester involving the N-terminal Cys
# The Author 2014. Published by Oxford University Press. All rights reserved.
For Permissions, please e-mail: journals.permissions@oup.com
481
Protein Engineering, Design & Selection vol. 27 no. 12 pp. 481–488, 2014
Published online October 21, 2014 doi:10.1093/protein/gzu048
 at O
U
P site access on February 29, 2016
http://peds.oxfordjournals.org/
D
ow
nloaded from
 
Downloaded from https://academic.oup.com/peds/article-abstract/27/12/481/1546888
by University of Zurich user
on 31 July 2018
residue of the intein, a reversible transesterification resulting
from the attack of a second Cys located just next to the
C-terminus of the intein on the thioester, intein excision due to
succinimide formation at the intein C-terminal asparagine
residue, and finally formation of a native amide bond between
the two protein parts by a S!N acyl shift at the thioester
(Xu and Perler, 1996; Xu and Evans, 2001). In nature this
intein self-cleavage occurs spontaneously and does not
require additional cofactors (Chong et al., 1996). For the pro-
duction of cyclic peptides a commercially available system,
IMPACTTM-TWIN (New England Biolabs, Inc., MA, USA),
has been designed, in which the respective protein or peptide
is sandwiched between two specifically engineered inteins, i.e.
the N-terminal Ssp DnaB intein (intein-1) (Mathys et al.,
1999) and the C-terminal Mth RIR1 intein (intein-2) (Evans
et al., 1999b). To suppress self-cleavage of the inteins from
the cyclic protein precursor during expression and initial puri-
fication, intein-1 lacks its N-terminal Cys residue while
intein-2 is devoid of its C-terminal Asn. After transesterifica-
tion of the thioester generated by N!S acyl shift at the
N-terminus of intein-2 with small thiol compounds such as
1,4-dithiothreitol (DTT) or 2-mercaptoethanesulfonic acid
(MESNA) and cleavage of intein-1 via temperature- or
pH-induced succinimide formation at its C-terminal Asn
residue, a linear protein intermediate with a N-terminal Cys
residue and a C-terminal activated thioester is obtained, which
undergoes fast intramolecular cyclization (Xu and Evans,
2001). Instead of intein-1 a protease cleavage site can also be
used to generate the N-terminal Cys residue at the protein
intermediate required for the ligation reaction (Camarero and
Muir, 1999). Chitin binding domains (CBD) (Watanabe et al.,
1994) joined to each intein facilitate the affinity purification of
the precursor protein by using a chitin resin.
However, there are several reports on this system that show
a surprisingly low protein yield or no protein production at all
(Mathys et al., 1999; Wood et al., 2000; Cui et al., 2006). The
main proposed reason is premature intein cleavage during
protein expression, probably provoked by cellular thiol com-
pounds. For some inteins, the C-terminal thioester formation
is also strongly dependent on the nature of the C-terminal
residue of the target protein. (Xu et al., 2000).
The research focus of our laboratory is on the investigation
of metallothioneins (MTs). MTs are small proteins with a high
percentage of Cys residues allowing them to coordinate metal
ions via formation of metal-thiolate clusters (Vasak et al.,
1981; Good and Vasak, 1986a,b; Messerle et al., 1992;
Freisinger, 2010). MTs are abundant in all phylae of life and
play roles in metal ion tolerance and homeostasis. Recent
reports show that MTs can also participate in the scavenging
of reactive oxygen species (Gobel et al., 2000; Colangelo et al.,
2004). In its metal-free form MTs are generally proposed to
adopt a highly flexible random coil structure mainly due to the
absence of secondary structural elements (Boulanger et al.,
1983) emphasizing the importance of metal ion binding for the
formation of distinct three-dimensional structures. Our attempts
to produce backbone cyclized MT species were driven by
mainly two objectives, the further stabilization of the three-
dimensional structure by reducing the flexibility of the protein
termini in order to facilitate crystallization and structure solu-
tion by nuclear magnetic resonance (NMR) as well as enhance-
ment of metal ion binding affinity and specificity by reduction
of metal ion binding site flexibility.
In this work we describe the production of a backbone
cyclized form of the g-domain from the seed-specific Ec-1 MT
isolated from Triticum aestivum (common bread wheat). This
protein is assumed to participate in Zn(II) storage for the ger-
mination process (Hanleybowdoin and Lane, 1983; Lane
et al., 1987) and forms two metal ion binding domains, i.e.
g- and bE-Ec-1, which coordinate two and four Zn(II) ions,
respectively (Peroza et al., 2009a), and whose structures have
been determined with NMR spectroscopy (Peroza et al.,
2009b; Loebus et al., 2011). The two metal ions in g-Ec-1 are
arranged in a Zn2Cys6 cluster (Loebus et al., 2011). To
achieve backbone cyclization, we used a modified version of
the IMPACTTM-TWIN system that we optimized for our
purpose and show that the high Cys content of MTs is not a
hurdle for efficient cyclization.
Materials and methods
Vector construction
A nucleotide sequence consisting of a 50 NdeI restriction site,
a sequence encoding for a Tobacco etch virus (TEV) protease
cleavage site, the Escherichia coli codon usage optimized
g-Ec-1 sequence (Peroza and Freisinger, 2007), and a 3
0 SpeI
restriction site was constructed de novo from commercially
obtained primer sequences in three PCR steps (see
Supplementary Material). In addition, a second sequence
including the codons for a N-terminal 6xHis tag was prepared
from the first construct using an additional primer.
Both final PCR products were digested with NdeI and SpeI
and ligated into the double digested and dephosphorylated
pTWIN2 vector (New England Biolabs Inc., Supplementary
Fig. S1). In this way plasmids lacking the N-terminal intein-1
are obtained, i.e. plasmid pTWIN2cut-gEc1 encoding for the
TEV-gEc1-intein2-CBD construct and plasmid pTWIN2cut-
6H-gEc1 encoding for the 6xHis-TEV-gEc1-intein2-CBD.
The original pTWIN2 plasmid and all restriction enzymes
were from New England Biolabs, Inc.
Expression of fusion proteins
Escherichia coli (BL 21 line) cells transformed with plasmids
pTWIN2cut-gEc1 or pTWIN2cut-6H-gEc1 were grown in
Luria-Bertani (LB) medium (Roth AG, Arlesheim, Switzerland)
supplemented with 100 mg ml21 ampicillin (Roth AG) at 378C.
Protein expression was induced at OD600 0.6 with 500 mM
isopropyl b-D-1-thiogalactopyranoside (IPTG) (Biosolve
Chimie, Dieuze, France) and media were supplemented with
ZnCl2 to a final concentration of 100 mM. Cells were harvested
after 3 h at 308C by centrifugation (4000 r/min, 15 min) and
the pellets were frozen in liquid nitrogen for lysis and future
purification.
Purification of the 6xHis-TEV-gEc1-intein2-CBD construct
Cell pellets were resuspended in Buffer A (20 mM Na phos-
phate, pH ¼ 7.2, 300 mM NaCl, 5% glycerol) and lysed by
sonication. Cell debris was removed by centrifugation and fil-
tration through a 0.22 mm filter, and the soluble cell extract
was applied to a HisTrap HP column (GE Healthcare Europe
GmbH, Glattbruck, Switzerland) that was pre-equilibrated
with Buffer A. After washing with Buffer A supplemented
with 30 mM imidazole, the fusion protein was eluted with
Buffer A containing 400 mM imidazole. The elution fraction
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was supplemented with 0.3 mM tris(2-carboxyethyl)phosphine
(TCEP) and immediately subjected to a desalting and buffer
exchange step with size-exclusion chromatography using a
HiLoad 16/600 Superdex 200 pg column (GE Healthcare) that
was pre-equilibrated with Buffer B (20 mM Na phosphate,
pH¼ 7.2, 100 mM NaCl). Fractions containing the fusion con-
struct were combined and used for TEV protease cleavage.
Fusion protein cleavage with TEV protease
The purified 6xHis-TEV-gEc1-intein-2-CBD fusion protein
was incubated with TEV protease (expressed and purified
according to (Tropea et al., 2009)) in a ratio of 10 : 1 based on
OD280 in Buffer B additionally containing 0.3 mM TCEP for
1 h at 48C and another 0.5 h at room temperature with constant
shaking.
On-column cyclization reaction
The mixture after TEV cleavage was slowly, i.e., 1 ml min21
applied to a column (d ¼ 10 mm, L ¼ 40 mm) containing
chitin resin (New England Biolabs) that was pre-equilibrated
with Buffer B. Cleavage of the intein-2 was initiated by addition
of two column volumes of Buffer B4 (20 mM Tris–HCl, pH ¼
8.5, 300 mM NaCl, 50 mM MESNA). After overnight incuba-
tion at 48C with gentle agitation using a rocking platform
shaker, the circular product was eluted from the column and
concentrated to 2 ml using a stirred ultrafiltration cell and a
membrane with a molecular weight cut-off of 1 kDa (Millipore
AG, Zug, Switzerland).
Purification of the TEV-gEc1-intein-2-CBD construct
After cell lysis and preparation of the soluble cell extract as
described above for the 6xHis construct, but using Buffer B2
(20 mM Tris–HCl, pH ¼ 7.0, 150 mM NaCl), further purifi-
cation was either started with a fusion protein capture step
using a chitin column or the cell extract was directly applied to
a size exclusion column.
For the purification starting with the capture step, 15 ml of
cell extract were again slowly loaded on a chitin column pre-
equilibrated with Buffer B2 followed by a washing step with
80 ml B2. Intein cleavage was induced by addition of Buffer
B4 (20 mM Tris–HCl, pH ¼ 8.5, 150 mM NaCl, 50 mM
MESNA) and overnight incubation at 48C. The eluted fraction
(15 ml) was concentrated to 4 ml using the stirred ultrafiltra-
tion cell and loaded on a HiLoad 16/600 Superdex 30 pg size
exclusion column (GE Healthcare) pre-equilibrated with
25 mM Tris–HCl, pH ¼ 7.5, 10 mM NaCl. The fraction con-
taining the precursor protein was incubated with TEV protease
in the ratio of 3 OD280 of fusion protein construct to 1 OD280
of TEV protease overnight at 48C with gentle mixing in the
same buffer. For the separation of linear and cyclic protein
species, first potentially present disulfide bridges were reduced
by incubation with 100 mM DTT for 40 min at 508C and sub-
sequently the metal clusters and hence the three-dimensional
structure of the proteins were broken up by acidification of the
solution to pH ¼ 2 with HCl followed by a final separation
step using a Superdex Peptide 3.2/300 size exclusion column
(GE Healthcare).
For the purification without a prior capture step, 5 ml of the
clear cell extract obtained from 1/3 l of cell culture was direct-
ly applied to a HiLoad 16/600 Superdex 200 pg column that
was pre-equilibrated with 20 mM ammonium acetate, pH 7.5.
The fraction containing the fusion construct was subjected to
TEV cleavage using a ratio of 10 OD280 of construct to 1
OD280 of TEV protease and incubated for 4 h at 48C, 1 h at
208C and 0.5 h at 378C. Subsequent on-column intein cleav-
age using a chitin column was performed as described for the
His-tagged construct followed by size exclusion chromatog-
raphy using the Superdex Peptide 3.2/300 column (10 mM
ammonium acetate, pH 7.5).
Preparation of apo-cyc-g-Ec-1
For the demetallation of the cyclic g-Ec-1 form, i.e.
cyc-g-Ec-1, the cyclic peptide was incubated with 30 mM
TCEP for 40 min at acidic pH (30 mM TCEP reduce the pH to
2–3) and applied to a Superdex Peptide 3.2/300 column, pre-
equilibrated with 10 mM HCl and using a flow rate of
0.4 ml min21.
Mass spectrometry
Protein samples in 10 mM ammonium acetate, pH 7.5, or in
10 mM HCl for the analysis of the metal-bound or apo-form,
respectively, were injected into a quadropole time-of-flight
(TOF) Ultima API spectrometer (Waters, UK). Scans were
accumulated and processed by the software MassLynx 3.5
(Micromass). Spectra were deconvoluted using the maximum
entropy algorithm (MaxEnt1 in MassLynx 3.5). Electrospray
parameters were capillary 2.8 V, cone 60 V and source tem-
perature 808C.
Protein quantification
Cyc-g-Ec-1 concentrations were determined by quantification
of thiolate groups with 2,20-dithiodipyridine (2-PDS) at pH 4.0
(Pedersen and Jacobsen, 1980). 2-PDS reacts with free
reduced thiol groups leading to the formation of thiopyridi-
none which can be quantified via its absorption at 343 nm
(1343 7600 M
21 cm21). Protein concentrations were calculated
based on six Cys residues per protein molecule.
SDS–PAGE
Protein separation was performed in 14% Tris-tricine poly-
acrylamide gels under denaturing conditions (Scha¨gger and
Vonjagow, 1987; Scha¨gger, 2006). For visualization of pro-
teins with a high Cys content, the protein samples were incu-
bated with 4 mM monobromobimane (mBBr) for 20 min in
the dark before denaturation with SDS loading buffer (Meloni
et al., 2005). After running the gel, unreacted mBBr was
removed by incubation of the gel in 50% methanol for 1 h.
Visualization of the bands based on fluorescence detection of
formed mB-thioethers (mBSR) was performed on the
UV-transilluminator Bio Vision 3026 using a filter for ethi-
diumbromide detection. As protein molecular mass marker
Fermentas PageRulerTM Prestained Protein Ladder (Thermo
Fisher Scientific, Inc., Rockford, IL, USA) was used.
Results and discussion
Cyclization of proteins increases their stability and reduces
their flexibility which should promote structural investiga-
tions. In addition, restrictions imposed on the conformational
flexibility of a metal-binding protein might influence the en-
vironment of the coordination sites in such a way that higher
specificity for a certain metal ion is achieved. However,
also the opposite can be true, i.e. disturbance of metal ion
binding by imposing unfavorable steric strain on the metal ion
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coordinating ligands. To optimize protein cyclization for our
needs we first attempted the cyclization of a small MT of
known structure, i.e. the g-domain of the wheat MT Ec-1. To
ensure backbone cyclization without steric strain, we added an
additional six amino acids long linker (GAAGAG) to the
C-terminus of the g-domain based on the NMR structure of
the linear protein (Loebus et al., 2011). The structure of this
cyclic construct obtained in the here described way was also
subsequently determined by NMR spectroscopy (Fig. 1A) and
revealed no changes compared with the linear form (Tarasava
et al., 2013).
For the cyclization of the g-Ec-1 domain we chose the
pTWIN2 vector of the IMPACTTM-TWIN system (New
England Biolabs) (Evans et al., 1999a) as a basis. The vector
contains an N-terminal-modified Ssp DnaB intein denoted
herein as intein-1, (Mathys et al., 1999) as well as a C-terminal
modified Mth RIR1 intein denoted as intein-2 (Evans et al.,
1999b), each fused to a chitin-binding domain (CBD) for puri-
fication. This system allows the generation of circular proteins
after recombinant expression of the precursor protein in
E. coli. Nevertheless, previous trials in our lab with this
expression system revealed extensive cleavage of both inteins
already during protein expression (unpublished data).
Cleavage of intein-1 is not unexpected as the conditions for
succinimide formation at the C-terminus of intein-1 are close
to the cytoplasmic pH of 7 and ambient temperature. Cleavage
of intein-1 and the concomitant formation of the free
N-terminal Cys residue at the target protein already during
protein expression can then facilitate preliminary cleavage of
also intein-2 even without addition of thiol reagents (Gao
et al., 2012). Purification of the concomitantly formed circular
peptides directly from the cell lysate is however difficult.
Hence, to prevent premature formation of the N-terminal
Cys we replaced intein-1 with a TEV protease cleavage site
(Tolbert and Wong, 2002) generating the TEV-gEc1-intein2-
CBD construct (Fig. 1B, top). In contrast to other proteases
TEV protease tolerates a number of different amino acids,
among them Cys, in the P10 position, hence the position direct-
ly following the protease recognition site (Kapust et al., 2002).
In this way an N-terminal Cys residue is generated at the target
protein after cleavage with TEV protease. Nevertheless, even
in the absence of a free N-terminal Cys residue still a large
amount of cleaved intein-2 was observed during protein purifi-
cation with the chitin column (Supplementary Fig. S2).
Presumably, this is triggered by an internal thiol compound,
i.e. a Cys residue (see discussion below), and hence cannot be
completely avoided. Nevertheless, the yield of full-length pre-
cursor protein (Fig. 1B, top) was slightly increased by keeping
the expression time to a minimum, i.e. 3 h at 308C. The
TEV-gEc1-intein2-CBD construct was separated from the cell
extract using a chitin column. Elution from the column and
hence cleavage of intein-2 by thioester formation was induced
by MESNA. After incubation with TEV protease and purifica-
tion by size exclusion chromatography, a mixture of linear and
circular g-domains was obtained (Fig. 2). Apart from a prob-
able unfavorable protein conformation for efficient cycliza-
tion, the reason for the formation of linear species can also
be the sensitivity of the C-terminal thioester for hydrolysis at
neutral or even slightly alkaline pH, competing with the cyc-
lization reaction via transesterification or occurring even
before formation of the N-terminal Cys-residue by TEV prote-
ase cleavage.
The separation of the linear g-Ec-1 domain from its circular
form is challenging. Naturally, most of their biophysical prop-
erties such as the isoelectric point and the degree of hydropho-
bicity are the same, and their hydrodynamic radii are too small
and too similar to enable efficient separation by size exclusion
chromatography. One method to isolate a backbone-cyclized
protein from its linear contaminant is the addition of a short
C-terminal 3xHis tag to the target protein in the fusion protein
precursor, which will be included in the cyclic protein after
the successful ring closure reaction (Iwai and Plu¨ckthun,
Fig. 1. (A) NMR solution structure of the cyclic Cd2-g-Ec-1 domain of a wheat MT (pdb entry 2MFP) in ribbon representation (Tarasava et al., 2013). The
additional amino acid linker (GAAGAG) is shown in light gray, Cd(II) ions as light gray spheres, and the Cys residues in stick mode. (B) Amino acid sequences
and schematic representation of the two different protein precursors used in this study. The N-terminal white box contains the TEV protease cleavage site
(ENLYQF), the gray box shows the sequence of the g-Ec-1 with Cys residues highlighted in large bold letters. Small size letters indicate additional amino acids
added as linkers to enable cyclization without steric strain (gray box) or to facilitate cloning and TEV cleavage (small letters in white box).
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1999). Treatment of the mixture after the cyclization reaction
with an exopeptidase will remove the 3xHis tag from the
linear form, while the integrity of the cyclic peptide is retained
and it can be captured with an immobilized metal ion affinity
chromatography (IMAC) column. This method, however, is
not applicable for MTs as the additional 3xHis tag will remain
in the final cyclic product. His residues are, however, also
good ligands for, e.g. Zn(II) ions and hence can interfere with
the metal-thiolate cluster formation that is crucial for correct
folding of the MT. Another method that has been described is
the selective precipitation of the linear peptide form by heat
denaturation due to the usually increased stability of cyclic
peptides compared with their linear forms (Iwai and
Plu¨ckthun, 1999). However, as MTs are generally very tem-
perature stable probably owing to the lack of secondary struc-
tural elements this approach is also not feasible here.
Due to the difficulties in separating the linear and cyclic
forms efficiently from each other, a procedure is needed that
excludes formation of the linear form concurrent to protein
cyclization. To prevent hydrolysis of the C-terminal thioester
resulting in the linear form, exposure time of the thioester to
the aqueous buffer should be kept to a minimum. Accordingly,
TEV protease cleavage and hence generation of the reactive
N-terminal Cys residue have to be performed before intein
cleavage. This approach can be accomplished in three differ-
ent ways. The easiest way, which should produce rather pure
cyclic proteins in a single step, would be to perform TEV
cleavage of the precursor protein bound to the chitin column.
However, after elution, mainly uncleaved TEV-g-Ec-1 species
were observed, most likely caused by low accessibility of the
cleavage site when bound to the chitin column (Supplementary
Fig. S3). Accordingly, at least for the here presented system per-
formance of TEV cleavage in batch mode is crucial. The most
simplistic approach would be direct incubation of the cleared
cell extract with TEV protease, which however led to massive
precipitation and inactivation of the protease due to buffer in-
compatibility. Hence a pre-capturing step for the g-Ec-1 pre-
cursor protein from the cell lysate seems to be essential, but the
intein-tag cannot be used for this as elution of the intact pre-
cursor protein from the chitin column requires denaturing con-
ditions and would further complicate the consecutive steps.
Hence an additional 6xHis purification tag N-terminal of the
TEV protease cleavage site was introduced (Fig. 1B, bottom)
(Tolbert and Wong, 2002) and the purification and cyclization
performed as illustrated in Fig. 3 and described in the following.
Samples taken during the different purification steps were ana-
lysed with SDS–PAGE (Fig. 4). The clarified cell lysate was
passed over an IMAC column to efficiently capture the full-
length precursor protein via its 6xHis tag while the prematurely
cleaved intein tag is found in the flow-through (Fig. 4, Lane 3).
The precursor protein is eluted from the IMAC column with
Fig. 2. ESI-MS spectrum of the final product obtained after purification and cyclization of the TEV-gEc1-intein2-CBD construct (Fig. 1B, top) showing the
presence of a mixture of cyclic (calc. 2770.1 Da) and linear g-Ec-1 (calc. 2788.1 Da) species.
Fig. 3. Scheme of cyclic g-Ec-1 production using the
6xHis-TEV-gEc1-intein2-CBD construct (Fig. 1B, bottom). See the detailed
description in the text.
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imidazole and subjected to TEV protease cleavage in batch
mode after buffer exchange with size exclusion chromatography
(Lane 6). Again premature cleavage of the intein tag is observed
(Lanes 5 and 6). Subsequently, the cleaved protein now bearing
the N-terminal Cys residue is captured with a chitin column,
getting rid at the same time of linear g-Ec-1 species with
cleaved intein-2 tags. On-column induction of intein self-
cleavage and thioester formation followed by cyclization is
induced with MESNA. The cyclic protein is then eluted from
the chitin column and is free of any contaminations with its
linear form according to SDS–PAGE (Lane 9). The purity was
further checked with size exclusion chromatography. As the
three-dimensional structures of the cyclic and the linear forms
are closely similar owing to the metal-thiolate clusters that
dictate the three-dimensional structures of the proteins, the
protein fraction was acidified to pH 2 which provokes metal ion
release from the proteins. The hydrodynamic radii of the apo-
forms obtained in this way should be significantly different.
Nevertheless, subsequent performance of size exclusion chroma-
tography at acidic pH reveals a single symmetric elution peak
(Supplementary Fig. S4), which is another strong indication for
the purity of the cyclic protein. Finally, this was confirmed by an
ESI-MS spectrum taken with the purified sample (Fig. 5). The
total yield of purified apo-form of cyclic g-Ec-1 was 0.7 mg per
liter of cell culture. For comparison, the final yield of linear
g-Ec-1 prepared using the glutathione S-transferase tag was 4 mg
per liter of cell culture (Loebus et al., 2011).
Rather puzzling is the observation that intein cleavage
apparently also takes place while the protein precursor is
bound to the IMAC column although no additional thiol com-
pounds are present (Fig. 4, Lanes 4 and 5). Tests with the pre-
cursor protein revealed that intein cleavage also occurs in pure
water (data not shown). Hence it is probable that cleavage
might be triggered by an internal thiol compound, i.e. a Cys
residue. This mechanism is known as the ‘thia zip cyclization’
of Cys-rich peptides (Tam et al., 1999a). Also internal
Cys-residues can undergo reversible transthioesterifications
with the C-terminal thioester and hence cause cleavage of the
intein tag. However, only the thioester formed with the
N-terminal Cys residue can rearrange via a S!N shift to form
a stable peptide bond and hence to finally yield the end-to-end
cyclized protein. The rate of this uncontrolled intein cleavage
depends on the number and the pattern of Cys residues in the
protein sequence (Tam et al., 1999a). The thia-zip mechanism
of cyclization and hence the premature cleavage of the intein
are supported by the fact that cleavage is inhibited when the
Cys residues are involved in disulfide bridge formation as
observed for the recombinant production of cyclotides (Garcia
et al., 2011). Significant reduction of the amount of intein
cleavage was also reported to occur in the presence of certain
metal ions, e.g. 2 mM Zn(II) (Mills and Paulus, 2001). This in-
hibition is reversible upon Zn(II) removal with EDTA.
Inhibition of intein cleavage can be easily explained by the
Fig. 4. Monitoring of cyclic g-Ec-1 production by SDS–PAGE. For visualizing of proteins with high Cys content all samples were stained with mBBr and the gel
visualized with fluorescence imaging. The silver stained gel can be found in the Supplementary Material (Supplementary Fig. S5). The single lanes show: the
protein marker (M), non-induced soluble cell extract (1), soluble cell extract after induction and 3 h expression at 308C (2), flow-through of IMAC column (3),
washing of IMAC column (4), elution from IMAC column with imidazole (5), TEV incubation (6), flow-through of chitin column (7), washing of chitin column
(8), elution from chitin column after incubation with MESNA (9), regeneration of chitin column with SDS (10).
Fig. 5. Non-deconvoluted ESI-MS spectra of fraction eluted from the chitin
column (Fig. 4., Lane 6) and further purified by size exclusion
chromatography (Supplementary Fig. S4) showing the exclusive presence of
cyclic g-Ec-1 (calc. 2770.1 Da). The linear species would be expected at a
molecular mass of 2788.1 Da. Additional small peaks belong to the sodium
(calc. 2792.1 Da) and the potassium adduct (calc. 2808.1 Da) of the cyclic
species. The inset shows the entire spectrum in the range of 2240–3260 Da
revealing the purity of the sample.
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formation of rather stable Cys thiolate-Zn(II) bonds, which
block the Cys residues for the thia-zip reaction. Inhibition by
Zn(II) is well applicable to our aim, the production of cyclic
MTs, as Zn(II) is the natural co-factor for many MTs and in
addition, also TEV protease is known to tolerate Zn(II) con-
centrations up to 5 mM without a significant reduction in
activity (Tropea et al., 2009). Incubation of the IMAC column
purified 6xHis-TEV-gEc1-intein2-CBD construct with in-
creasing concentrations of Zn(II) indeed reveal a significant
reduction of intein cleavage (Fig. 6A). To test reduction of the
pronounced intein cleavage during protein expression, LB
growth media, which already contain 10 mM Zn(II), were sup-
plemented with additional Zn(II) or Cd(II) after induction of
protein expression. While 0.1 mM Zn(II) or Cd(II) had no
effect, 1 mM Zn(II) caused strong inhibition of cleavage
(Fig. 6B). However, the reason for this inhibition is most
likely some sort of denaturation of the precursor protein as it is
now almost exclusively present in the insoluble fraction. If the
intein can be re-solubilized and its activity restored remains to
be evaluated.
Production of cyclic proteins with intein-based expression
and purification systems such as the IMPACTTM TWIN
system has the general drawback of generating mixtures of
cyclic and linear species that can be challenging to separate.
The major problem is the continuous slow cleavage of the
intein-tags during all steps. In an attempt to optimize the cyc-
lization of the Cys-rich g-Ec-1 domain of a wheat MT on the
basis of the pTWIN2 vector, we replaced the N-terminal intein
by a TEV cleavage site for the protection of N-terminal cyst-
eine residue. However, the C-terminal intein is crucial for
thioester formation. The here described optimized purification
procedure aimed to constantly remove species with the prelim-
inary cleaved intein tag at each stage of the process. In doing
so we were able to produce a highly pure cyclic protein. To
increase the yield the further reduction of self-cleavage by
protein engineering or the addition of reversible inhibitors
should be the focus of future investigations.
Supplementary Material
Supplementary Material are available at PEDS online.
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